DK1144006T3 - Synergistisk inhibering af HIV-1-fusion og -binding, præparater og antistoffer dertil - Google Patents

Synergistisk inhibering af HIV-1-fusion og -binding, præparater og antistoffer dertil

Info

Publication number
DK1144006T3
DK1144006T3 DK99966466T DK99966466T DK1144006T3 DK 1144006 T3 DK1144006 T3 DK 1144006T3 DK 99966466 T DK99966466 T DK 99966466T DK 99966466 T DK99966466 T DK 99966466T DK 1144006 T3 DK1144006 T3 DK 1144006T3
Authority
DK
Denmark
Prior art keywords
hiv
antibodies
preparations
fusion
binding
Prior art date
Application number
DK99966466T
Other languages
Danish (da)
English (en)
Inventor
William C Olson
Paul J Maddon
Original Assignee
Progenics Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Progenics Pharm Inc filed Critical Progenics Pharm Inc
Application granted granted Critical
Publication of DK1144006T3 publication Critical patent/DK1144006T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK99966466T 1998-12-16 1999-12-16 Synergistisk inhibering af HIV-1-fusion og -binding, præparater og antistoffer dertil DK1144006T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21279398A 1998-12-16 1998-12-16
US11253298P 1998-12-16 1998-12-16
PCT/US1999/030345 WO2000035409A2 (en) 1998-12-16 1999-12-16 Hiv-i fusion inhibition compounds

Publications (1)

Publication Number Publication Date
DK1144006T3 true DK1144006T3 (da) 2007-11-26

Family

ID=26810060

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99966466T DK1144006T3 (da) 1998-12-16 1999-12-16 Synergistisk inhibering af HIV-1-fusion og -binding, præparater og antistoffer dertil

Country Status (13)

Country Link
EP (2) EP1144006B1 (de)
JP (1) JP2002538771A (de)
AT (1) ATE375802T1 (de)
AU (3) AU773175B2 (de)
CA (1) CA2355607A1 (de)
CY (1) CY1107858T1 (de)
DE (1) DE69937369T2 (de)
DK (1) DK1144006T3 (de)
ES (1) ES2296416T3 (de)
HK (1) HK1041207B (de)
MX (1) MXPA01006097A (de)
PT (1) PT1144006E (de)
WO (1) WO2000035409A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996041020A1 (en) 1995-06-07 1996-12-19 Progenics Pharmaceuticals, Inc. Fluorescence resonance energy transfer screening assay for the identification of hiv-1 envelope glycoprotein-medicated cell
US7118859B2 (en) 1996-01-17 2006-10-10 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
AU2265701A (en) * 1999-12-16 2001-06-25 Tanox, Inc. Anti-hiv-1 conjugates for treatment of hiv disease
US7138119B2 (en) * 2000-09-15 2006-11-21 Progenics Pharmaceuticals, Inc. Compositions and methods for inhibition of HIV-1 infection
US7060273B2 (en) 2001-04-06 2006-06-13 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
US20020146415A1 (en) * 2001-04-06 2002-10-10 Olson William C. Methods for inhibiting HIV-1 infection
EP1456241B1 (de) * 2001-12-21 2005-03-16 Micromet AG Einzelne und duale anti-cd4-rantes chemokin/zytokin konstrukte
US7122185B2 (en) 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody
EP1478738B1 (de) * 2002-02-22 2008-11-12 Progenics Pharmaceuticals, Inc. Anti-ccr5 antikörper
TW200720289A (en) 2005-04-01 2007-06-01 Hoffmann La Roche Antibodies against CCR5 and uses thereof
WO2007085567A2 (en) * 2006-01-30 2007-08-02 F. Hoffmann-La Roche Ag Synergistic compositions for treating hiv
AU2007286451A1 (en) 2006-08-17 2008-02-21 F. Hoffmann-La Roche Ag A conjugate of an antibody against CCR5 and an antifusogenic peptide
TW200817438A (en) 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
ATE550355T1 (de) 2006-09-29 2012-04-15 Hoffmann La Roche Antikörper gegen ccr5 und ihre verwendung
CL2008000707A1 (es) 2007-03-13 2008-09-22 Hoffmann La Roche Conjugado de polipeptidos antifusogenicos y polipeptidos derivados de la cabeza globular del factor del complemento c1q; composicion farmaceutica que lo comprende; su uso para tratar infecciones viricas; y metodo de produccion.
WO2013024022A1 (en) 2011-08-12 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for treatment of pulmonary hypertension
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3375697A (en) * 1996-05-28 1998-01-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Cc chemokine receptor 5, antibodies thereto, transgenic animals
EP0956044A4 (de) * 1996-06-14 2005-01-05 Progenics Pharm Inc Verwendungen eines chemokin-rezeptors zur inhibierung einer hiv-1 infektion
US6528625B1 (en) * 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same

Also Published As

Publication number Publication date
ES2296416T3 (es) 2008-04-16
EP1144006B1 (de) 2007-10-17
EP2088158A3 (de) 2010-01-20
DE69937369D1 (de) 2007-11-29
HK1041207A1 (en) 2002-07-05
CY1107858T1 (el) 2013-06-19
WO2000035409A3 (en) 2000-09-14
EP1144006A2 (de) 2001-10-17
AU2004205165A1 (en) 2004-09-16
HK1041207B (en) 2007-12-28
EP2088158A2 (de) 2009-08-12
MXPA01006097A (es) 2002-04-15
WO2000035409A2 (en) 2000-06-22
AU2004205164A1 (en) 2004-09-16
DE69937369T2 (de) 2008-07-24
EP1144006A4 (de) 2004-11-24
PT1144006E (pt) 2007-12-11
CA2355607A1 (en) 2000-06-22
AU2199600A (en) 2000-07-03
ATE375802T1 (de) 2007-11-15
AU773175B2 (en) 2004-05-20
JP2002538771A (ja) 2002-11-19

Similar Documents

Publication Publication Date Title
CY1107858T1 (el) Ccr5 αντισωματα pa14
ATE208820T1 (de) Humanisierte antikoerper
KR960704938A (ko) Fas 길항제 및 그의 용도(Fas Antagonists and Uses Thereof)
NO942912L (no) Konstruksjon, kloning og ekspresjon av humaniserte, monoklonale antistoffer mot humant interleukin-5
UA89017C2 (uk) ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b
ATE324381T1 (de) Mutiertes scfv-fragment des okt-3 antikörpers
KR960704576A (ko) CD40에 대한 항체(Antibodies to CD40)
PE20001316A1 (es) Anticuerpo humanizado especifico para 4-1bb humano y composicion farmaceutica que lo contiene
ES2187954T3 (es) Anticuerpos anti-integrina avb3 antagonistas.
WO2003078468A3 (de) Verwendung einer an cd28 bindenden wirksubstanz zur herstellung einer pharmazeutischen zusammensetzung
EP0603307A4 (de) Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung.
PT1308507E (pt) Anticorpo monoclonal anti-núcleo de hcv
DK1860188T3 (da) Human cytokin-receptor
WO2003048194A3 (de) Peptid oder protein enthaltend ein c'-d loop der cd28 rezeptorfamilie
MXPA05002894A (es) Metodos para regular el cancer.
AU2707992A (en) Monoclonal antibodies to hepatitis c virus
MX9702422A (es) Anticuerpos recombinantes contra fas y adn para los mismos.
EP0155172A3 (de) Monoklonale Antikörper gegen menschlichen Lungenkrebs
BR9702101A (pt) Hibridoma e anticorpo monoclonal
BR0007827A (pt) Anticorpos e fragmento fv que reconhecemantìgeno ior c2
CA2137551A1 (en) A novel endothelial cell molecule mediating lymphocyte binding in man
DK1161522T3 (da) Fremgangsmåde til isolering af CD8+-celler og beslægtede hybridomaceller, antistoffer og polypeptider
EP0349258A3 (de) Verfahren zur Bestimmung der Differenzierung einer menschlichen T-Zelle
DK557187D0 (da) Murin hybridoma lym-1, dermed fremstillet monoklonalt antistof og fremgangsmaade til fremstilling af antistoffet
DK557287A (da) Murin hybridoma lym-2, dermed fremstillet monoklonalt antistof og fremangsmaade til fremstilling af antistoffet